These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38805909)

  • 21. Nintedanib for the treatment of idiopathic pulmonary fibrosis.
    Varone F; Sgalla G; Iovene B; Bruni T; Richeldi L
    Expert Opin Pharmacother; 2018 Feb; 19(2):167-175. PubMed ID: 29327616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-peptidic immunoproteasome β5i-selective inhibitor as potential treatment for idiopathic pulmonary fibrosis: Virtual screening, hit evolution and lead identification.
    Li Y; Nan G; Hou X; Yan Y; Yang Y; Yang Y; Li K; Xiao Z
    Eur J Med Chem; 2023 Dec; 261():115856. PubMed ID: 37826934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis.
    Zhu Y; Zheng X; Wang C; Sun X; Sun H; Ma T; Li Y; Liu K; Chen L; Ma X
    Bioorg Med Chem; 2020 Jan; 28(2):115254. PubMed ID: 31866272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel N
    Zheng L; Chen K; Xie Y; Huang J; Xia C; Bao YX; Bi H; Wang J; Zhou ZZ
    Eur J Med Chem; 2024 Nov; 277():116710. PubMed ID: 39098133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients.
    Proesmans VLJ; Drent M; Elfferich MDP; Wijnen PAHM; Jessurun NT; Bast A
    Lung; 2019 Oct; 197(5):551-558. PubMed ID: 31440832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
    Udalov S; Dumitrascu R; Pullamsetti SS; Al-tamari HM; Weissmann N; Ghofrani HA; Guenther A; Voswinckel R; Seeger W; Grimminger F; Schermuly RT
    BMC Pulm Med; 2010 May; 10():26. PubMed ID: 20444277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
    Purushothaman B; Arumugam P; Kulsi G; Song JM
    Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of 7-alkoxybenzofurans as PDE4 inhibitors with hepatoprotective activity in D-GalN/LPS-induced hepatic sepsis.
    Xia C; Wen H; Zheng L; Ni Y; Bi H; Wang H; Xu J; Zhou ZZ
    Eur J Med Chem; 2024 Sep; 275():116576. PubMed ID: 38861808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
    Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
    BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
    Guariento S; Karawajczyk A; Bull JA; Marchini G; Bielska M; Iwanowa X; Bruno O; Fossa P; Giordanetto F
    Bioorg Med Chem Lett; 2017 Jan; 27(1):24-29. PubMed ID: 27890378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis.
    Skurikhin E; Nebolsin V; Widera D; Ermakova N; Pershina O; Pakhomova A; Krupin V; Pan E; Zhukova M; Novikov F; Sandrikina L; Morozov S; Kubatiev A; Dygai A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenylated flavonoids as potent phosphodiesterase-4 inhibitors from Morus alba: Isolation, modification, and structure-activity relationship study.
    Guo YQ; Tang GH; Lou LL; Li W; Zhang B; Liu B; Yin S
    Eur J Med Chem; 2018 Jan; 144():758-766. PubMed ID: 29291443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification.
    Liao Y; Jia X; Tang Y; Li S; Zang Y; Wang L; Cui ZN; Song G
    Bioorg Med Chem Lett; 2019 Nov; 29(22):126720. PubMed ID: 31610942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
    Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
    J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors.
    Huang L; Shan W; Zhou Q; Xie J; Lai K; Li X
    Bioorg Med Chem Lett; 2014 Jan; 24(1):249-53. PubMed ID: 24300734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of indoline-based derivatives as effective ROCK2 inhibitors for the potential new treatment of idiopathic pulmonary fibrosis.
    Fu S; Wen Y; Peng B; Tang M; Shi M; Liu J; Yang Y; Si W; Guo Y; Li X; Yan T; Kang J; Pei H; Chen L
    Bioorg Chem; 2023 Aug; 137():106539. PubMed ID: 37163811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials.
    MacIsaac S; Somboonviboon D; Scallan C; Kolb M
    Expert Opin Emerg Drugs; 2024 Jun; 29(2):177-186. PubMed ID: 38588523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents.
    Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S
    Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.